Home › Funds › Stonepine Capital Management, LLC › MIRM
Stonepine Capital Management, LLC position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
Stonepine Capital Management, LLC reported holding 40,000 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 3.22% of its reported portfolio and ranking #9 among its reported holdings. Stonepine Capital Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's MIRM position evolved
Stonepine Capital Management, LLC first disclosed a stake in MIRM in Q3 2026 at 40,000 shares (US$4.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 40.00K | $4.20M | New |
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), TANG CAPITAL MANAGEMENT LLC (US$144.7M), Novo Holdings A/S (US$131.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $106.72M · Q3 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K sh · $52.21M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K sh · $48.66M · Q2 2026
- Palo Alto Investors LP 348.81K sh · $40.83M · Q2 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held MIRM?
Stonepine Capital Management, LLC has disclosed MIRM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Stonepine Capital Management, LLC's current position in MIRM?
As of Q3 2026, Stonepine Capital Management, LLC holds 40.00K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $4.20M, representing 3.22% of its reported portfolio and ranking #9.
Has Stonepine Capital Management, LLC been buying or selling MIRM?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC newly opened its position in MIRM.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., TANG CAPITAL MANAGEMENT LLC, Novo Holdings A/S, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.